Bit.bio

Manufacturer of programmed human cells for research and drug discovery

placeCambridge, England, United Kingdom calendar_todayFounded 2016 groups52 employees language bit.bio

Registered entities

Social engagement

Social engagement: 27.5K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

55 investors on record; lead investors include Resilience, Puhua Capital, Charles River Laboratories, Foresite Capital.

Investor typeCountShare
Venture capital1425%
Private equity47%
Accelerator & incubator12%
Other / undisclosed3665%

Recent activity

1 Jul 2026
Event
FENS2026
30 Jun 2026
Product launch
ioHepatocytes
25 Jun 2026
Event
Human Cell Forum 2026
Coming soon